Revolution Medicines (MIL:1RVMD) Other Operating Expense: €0.00 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:1RVMD Revolution Medicines Inc MIL:1RVMD
9 GF Score
Price €178.40
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Revolution Medicines Other Operating Expense?

Revolution Medicines MIL:1RVMD +4.60% 9 Other Operating Expense is €0.00 Mil as of Jun. 2026. GuruFocus rates MIL:1RVMD with a GF Score™ of 9/100 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Revolution Medicines's Other Operating Expense for the three months ended in Jun. 2026 was €-0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 was €0.00 Mil.

Revolution Medicines's quarterly Other Operating Expense declined from Dec. 2025 (€0.00 Mil) to Mar. 2026 (€0.00 Mil) and declined from Mar. 2026 (€0.00 Mil) to Jun. 2026 (€-0.00 Mil).

Revolution Medicines's annual Other Operating Expense declined from Dec. 2023 (€0.00 Mil) to Dec. 2024 (€-0.00 Mil) but then increased from Dec. 2024 (€-0.00 Mil) to Dec. 2025 (€-0.00 Mil).

Revolution Medicines Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Revolution Medicines's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Revolution Medicines Other Operating Expense Chart

Revolution Medicines Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only -0.00 -0.00 0.00 -0.00 -0.00

Revolution Medicines Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 -0.00 0.00 0.00 -0.00
MIL:1RVMD
9GF Score
Revolution Medicines Inc MIL:1RVMD
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Revolution Medicines Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of €0.00 Mil mean?
Revolution Medicines (MIL:1RVMD) has a Other Operating Expense of €0.00 Mil as of Jun. 2026. Other operating expenses that a company records on its income statement. View historical data on Revolution Medicines and its competitors.
Is Revolution Medicines' Other Operating Expense too high?
Revolution Medicines' current Other Operating Expense is €0.00 Mil. Overall, Revolution Medicines has a GF Score™ of 9/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Revolution Medicines' Other Operating Expense compare to ALNY and ONC?
Revolution Medicines' Other Operating Expense of €0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Biotechnology company?
A good Other Operating Expense depends on the Biotechnology industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Revolution Medicines and its competitors. Revolution Medicines's current Other Operating Expense is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Revolution Medicines stock overvalued right now?
Based on GuruFocus' analysis, Revolution Medicines (MIL:1RVMD) is currently considered Significantly Overvalued. The current Other Operating Expense is €0.00 Mil. Revolution Medicines' overall GF Score™ is 9/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Revolution Medicines (MIL:1RVMD), the current Other Operating Expense is €0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Revolution Medicines Business Description

Other Exchanges RVMD:USA42Z:Germany
Address 700 Saginaw Drive, Redwood City, CA, USA, 94063
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
9GF Score

Get the complete analysis for MIL:1RVMD

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€178.40
Price